Navigation Links
Cordex Pharma Forms Heart Failure Medical Advisory Board
Date:2/11/2009

Dr. Joshua Hare to Chair the Board

LA JOLLA, Calif., Feb. 11 /PRNewswire-FirstCall/ -- Cordex Pharma, Inc. (OTC Bulletin Board: CDXP) announced today the formation of a Medical Advisory Board to provide clinical guidance for the Company's development program of CDP-1050 for the treatment of heart failure.

The Medical Advisory Board will play an important supportive role in the design and oversight of the planned CDP-1050 Phase 2 clinical trial and assist in addressing regulatory and patients' welfare issues. It is composed of internationally recognized leaders in the field of heart failure; all of whom have extensive experience in the design and execution of clinical trials aimed at improved care of patients with heart failure.

CDP-1050 is being developed as a new therapeutic modality in the management of heart failure. It targets the redox-nitiric oxide imbalance, which is increasingly recognized as a major factor in poor myocardial contractile efficiency, the hallmark manifestation of this disorder.

The Medical Advisory Board is chaired by Joshua M. Hare, M.D., the Louis Lemberg Professor of Medicine, Chief of the Division of Cardiology, and Director of the Interdisciplinary Stem Cell Institute at University of Miami, Miller School of Medicine. He has pioneered the use of stem cell therapy to repair damaged hearts. Dr. Hare has authored and co-authored numerous peer-reviewed publications including a report on a multi-center clinical trial with oxypurinol, a modifier of cellular redox potential, in patients with symptomatic heart failure. He served as the principal investigator of that clinical trial. Dr. Hare has also authored a New England Journal of Medicine editorial on redox-nitric oxide balance in the cardiovascular system.

Other members of the Medical Advisory Board include:

Wilson S. Colucci, M.D., is the Thomas J. Ryan Professor of
'/>"/>

SOURCE Cordex Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Cordex Pharma Presents New Frontiers in Cardiovascular Medicines on January 29
2. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
3. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
4. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
5. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
6. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Innovation is more urgent than ever. Radical ... the world and transforming global markets in industry ... health care, disruption is constantly underway. , As ... shake the foundations of established business models, large-scale ... survive the next wave of mega-change. , This ...
(Date:2/26/2015)... , Feb. 26, 2015  Dyadic International, Inc. ... patented and proprietary technologies are used to develop, ... the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme ... financial results for year ending December 31, 2014 ... and will host a conference call that day ...
(Date:2/26/2015)... , Feb. 26, 2015 Tauriga Sciences, Inc. ... company with interests in the natural wellness sector and ... today that its products will be featured at the ... Partners, 27 th Annual Growth Stock Conference on ... at 1 Ritz Carlton Drive, Dana Point ...
(Date:2/26/2015)... -- Spark Therapeutics (NASDAQ: ONCE ) announced today ... the Cowen and Company Health Care Conference on Wednesday, ... Boston Marriott Copley Place. To access the ... Cowen conference, please visit the "Upcoming Events" section within ... website at www.sparktx.com .  A replay of the ...
Breaking Biology Technology:One Million Acts of Innovation Canada Creates Partnership with The Economist Events’ Innovation Forum 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 3SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 2SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 3SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 4Spark Therapeutics to Participate in the 35th Annual Cowen and Company Health Care Conference 2
... (Amex: IMM ) will have an investor conference ... to discuss its financial results for the quarter,ended December ... Company,s,scientific and clinical progress. Investors and interested parties in ... (888) 338-8374 and callers,outside the U.S. should call (706) ...
... 6 Mediware Information,Systems, Inc. (Nasdaq: MEDW ) ... repurchase of up to $4 million of the company,s ... and Chief Executive Officer or Chief,Financial Officer of the ... obligation to repurchase shares under the program., Commenting, ...
... ... Services Network, POWAY, Calif., Feb. 6 ... diagnostic imaging systems,and services to physicians, offices, hospitals and imaging centers, ... American,Nuclear Medicine Equipment Product Line Strategy Award., Travis Chong, research ...
Cached Biology Technology:Immtech Investor Conference Call Scheduled for February 11, 2008 2Mediware Board Authorizes $4 Million Stock Buyback 2Digirad Corporation to Receive Frost & Sullivan 2007 North American Award for Product Strategy 2Digirad Corporation to Receive Frost & Sullivan 2007 North American Award for Product Strategy 3
(Date:2/5/2015)... OXFORD, Conn. , Jan. 28, 2015 ... ("NXT-ID" or the "Company"), a biometric authentication company focused ... present at the upcoming RedChip Global Online CEO Conference ... Gino Pereira , CEO of ... discussing its lead product, the Wocket smart wallet and ...
(Date:1/22/2015)... CHICAGO , Jan. 9, 2015 Valid S.A. ("Company") ... the market in general the State of Washington,s ... contract for a new enrollment and central issuance system for ... The project planning and development will start ...
(Date:1/22/2015)... 16, 2015  A man-made form of insulin delivered by ... capabilities in adults with mild cognitive impairment and Alzheimer,s ... researchers at Wake Forest Baptist Medical Center. ... mild cognitive impairment (MCI) or mild to moderate Alzheimer,s ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
... terms of diversity and sheer numbers, the microbes occupying ... inhabiting the Earth. Numbering in the tens of trillions ... microbiome, as it,s called, helps the body perform a ... understood. How this microbial mlange may be ...
... Toxoplasma gondii , a common parasite of people and ... report will appear online on January 19th in The ... response spares T. gondii -infected hosts from deadly infectionan ... survival of the host to ensure its own transmission. But ...
... MobileCop UnitsWALL, N.J., Jan. 13 ... leader in finger-based biometric identification and wireless public ... Lincoln, NE Police Department. The award was ... (PSIC) grant from the Department of Homeland Security ...
Cached Biology News:Our microbes, ourselves 2Our microbes, ourselves 3Our microbes, ourselves 4BIO-key(R) Mobile Data and Messaging Solutions Link Nebraska Law Enforcement Agencies 2BIO-key(R) Mobile Data and Messaging Solutions Link Nebraska Law Enforcement Agencies 3
Neuropilin-2 Purified Anti-Rat clone 54, Isotype Mouse IgG 1 , 150 µg Consult technical datasheet for details....
CBF-B (G-2)...
HSV-2 gD (0191)...
... Dynabeads Epoxy (4.5 m). Hydrophobic naked ... Ideal for coupling of antibodies for cell ... coupling with covalent binding of primary amine ... (SH)) occurring within 16-20 hours. Coupling reactions ...
Biology Products: